NITROGEN-CONTAINING AROMATIC DERIVATIVES, THEIR USING, MEDICINAL AGENT BASED ON THEREOF AND METHOD FOR TREATMENT Russian patent published in 2005 - IPC

Abstract RU 2264389 C2

FIELD: organic chemistry, medicine, pharmacy.

SUBSTANCE: invention relates to new nitrogen-containing aromatic derivatives of the general formula:

wherein Ag represents (1) group of the formula:

; (2) group represented by the formula:

or ; (3) group represented by the formula:

; Xg represents -O-, -S-, C1-6-alkylene group or -N(Rg3)- (wherein Rg3 represents hydrogen atom); Yg represents optionally substituted C6-14-aryl group, optionally substituted 5-14-membered heterocyclic group including at least one heteroatom, such as nitrogen atom or sulfur atom, optionally substituted C1-8-alkyl group; Tg1 means (1) group represented by the following general formula:

; (2) group represented by the following general formula: . Other radical values are given in cl. 1 of the invention claim. Also, invention relates to a medicinal agent, pharmaceutical composition, angiogenesis inhibitor, method for treatment based on these compounds and to using these compounds. Invention provides preparing new compounds and medicinal agents based on thereof in aims for prophylaxis or treatment of diseases wherein inhibition of angiogenesis is effective.

EFFECT: improved treatment method, valuable medicinal properties of compounds and agents.

40 cl, 51 tbl, 741 ex

Similar patents RU2264389C2

Title Year Author Number
ANTICANCER DRUG FOR THYROID CANCER 2007
  • Matsui Dzundzi
RU2448708C2
AGENT FOR PROPHYLAXIS AND TREATMENT OF NEUROPATHY 2003
  • Momose Jju
  • Sakai Nozomu
  • Maekava Tsujosi
  • Khazama Masatosi
  • Kavamura Toru
  • Sera Misajo
RU2337682C2
DERIVATIVES OF 5-PYRIDYL-1,3-AZOLE, METHOD FOR THEIR PREPARING, THEIR PRODRUG, PHARMACEUTICAL COMPOSITION, METHOD FOR ANTAGONISM OF ADENOSINE A3-RECEPTOR, METHOD FOR INHIBITION OF P38 MAP KINASE, METHOD FOR INHIBITION PRODUCING TNF-ALPHA AND METHOD FOR PROPHYLAXIS 2000
  • Okhkava Sigenori
  • Kanzaki Naojuki
  • Mivatasi Sejdzi
RU2237062C2
TABLET CONTAINING SPARINGLY SOLUBLE ACTIVE INGREDIENT 2006
  • Marunaka Sigejuki
  • Fukuta Makoto
RU2420278C2
HETEROCYCLIC COMPOUND 2018
  • Takami, Kazuaki
  • Seto, Masaki
  • Sasaki, Shinobu
  • Ando, Haruhi
  • Ogino, Masaki
  • Ohashi, Tomoko
  • Imaeda, Toshihiro
  • Fujimori, Ikuo
  • Tsukimi, Yasuhiro
  • Yamada, Masami
  • Shimokawa, Kenichiro
  • Wakabayashi, Takeshi
  • Murakami, Masataka
  • Fushimi, Makoto
  • Okawa, Tomohiro
  • Yonemori, Jinichi
  • Ohashi, Tomohiro
  • Suzuki, Hideo
  • Maezaki, Hironobu
  • Sato, Ayumu
  • Asano, Yasutomi
  • Swann, Steve
RU2791533C2
PYRIDIN DERIVATIVES AS DIPEPTIDYL PEPTIDASE IV INHIBITORS 2004
  • Oi Satoru
  • Maezaki Khironobu
  • Suzuki Nobukhiro
RU2353617C2
HETEROCYCLIC COMPOUND 2019
  • Sasaki, Shinobu
  • Asano, Yasutomi
  • Maezaki, Hironobu
  • Sato, Ayumu
RU2806347C2
DERIVATIVES OF 6-AMINO QUINAZOLINE OR 3-CYANOQUINOLINE, METHODS OF THEIR PRODUCTION AND THEIR APPLICATION AS INHIBITORS OF RECEPTOR TYROZINE KINASES EGFR OR HER-2 2010
  • Tan Pehn Cho
  • Li Sin'
  • Van Bin'
  • Van Tszjun'
  • Chehn' Litszjun'
RU2536102C2
PHARMACEUTICAL COMPOUNDS 2015
  • Boyle Robert George
  • Walker David Winter
  • Boyce Richard Justin
  • Peterson Scott
  • Farouz Francine
  • Vo Cong Hung
RU2687060C2
NEW P2X7 RECEPTOR ANTAGONISTS, METHOD OF OBTAINING THEM, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT AND USE, BASED ON ANTAGONISTS 2004
  • Ivans Richard
  • Ehjssejd Kristin
  • Ford Ronan
  • Martin Barri
  • Tompson Tobi
  • Uillis Pol
RU2347778C2

RU 2 264 389 C2

Authors

Funakhasi Jasukhiro

Tsuruoka Akikhiko

Matsukura Masajuki

Khaneda Toru

Fukuda Josio

Kamata Dzuniti

Takakhasi Keiko

Matsusima Tomokhiro

Mijazaki Kazuki

Nomoto Ken-Iti

Vatanabe Tatsuo

Obaisi Khirosi

Jamaguti Atsumi

Suzuki Sati

Nakamura Katsudzi

Mimura Fusajo

Jamamoto Judzi

Matsui Dzundzi

Matsui Kendzi

Josiba Takako

Suzuki Jasujuki

Arimoto Itaru

Dates

2005-11-20Published

2001-10-19Filed